Other3

DANAHER CORP /DE/

Total Value

$NaN

Filing Date

Oct 16, 2026

1 transactions

Trade Summary

On Oct 9, 2026, COMAS DANIEL L, Director, reported $NaN of DANAHER CORP /DE/ (DHR) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: COMAS DANIEL L
Role: Director
Location: WASHINGTON, DC

Filing Details

Filing Date: Oct 16, 2026
Transaction Date: Oct 9, 2026
Accession Number: 0000313616-26-000197
Form Type: 3

Want live alerts when COMAS DANIEL L trades again?

Download Insider Trades to track DHR, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents the participant's and/or Company's contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program (all contributions were made previously, during the reporting person's employment with the Company). The reported securities reflect unfunded, notional shares of Danaher common stock.
(F2)The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.
(F3)The notional shares convert on a one-for-one basis.
(F4)Date shown is grant date. Fifty percent of the options became or become exercisable on each of the fourth and fifth anniversaries of the grant date.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

COMAS DANIEL L

(Last)

(First)

(Middle)

2200 PENNSYLVANIA AVENUE, NW

SUITE 800W

(Street)

WASHINGTON

20037

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/09/2026

3. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	18,804	I	By Trust
Common Stock	46,915	I	By Grantor Retained Annuity Trust
Common Stock	2,543	I	By Spouse
Common Stock	6.061	I	By 401K

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Danaher Deferred Compensation Programs - Danaher Stock Fund⁽¹⁾	⁽²⁾	⁽²⁾	Common Stock	52,338.062	$0⁽³⁾	D
Employee stock option (right to buy)	02/24/2018⁽⁴⁾	02/24/2028	Common Stock	47,805	$88.24	D
Employee stock option (right to buy)	02/24/2019⁽⁴⁾	02/24/2029	Common Stock	23,146	$100.81	D
Employee stock option (right to buy)	02/24/2020⁽⁴⁾	02/24/2030	Common Stock	14,303	$139.3	D

Explanation of Responses:

1. Represents the participant's and/or Company's contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program (all contributions were made previously, during the reporting person's employment with the Company). The reported securities reflect unfunded, notional shares of Danaher common stock.

2. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.

3. The notional shares convert on a one-for-one basis.

4. Date shown is grant date. Fifty percent of the options became or become exercisable on each of the fourth and fifth anniversaries of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ James F. O'Reilly, attorney-in-fact for Daniel L. Comas	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 3 as rendered by the SEC from accession 0000313616-26-000197.

DANAHER CORP /DE/

Trade Summary

Company Information

Insider Information

Filing Details

Want live alerts when COMAS DANIEL L trades again?

Footnotes

SEC Form 3

SEC Filing

SEC Form 3